Advertisement
Advertisement

VKTX

VKTX logo

Viking Therapeutics, Inc

37.96
USD
Sponsored
-1.05
-2.68%
Jul 01, 13:05 UTC -4
Open

VKTX Earnings Reports

Positive Surprise Ratio

VKTX beat 22 of 42 last estimates.

52%

Next Report

Date of Next Report
Jul 29, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
-$1.24
Implied change from Q1 26 (Revenue/ EPS)
--
/
-9.49%
Implied change from Q2 25 (Revenue/ EPS)
--
/
+117.54%

Viking Therapeutics, Inc earnings per share and revenue

On Apr 29, 2026, VKTX reported earnings of -1.37 USD per share (EPS) for Q1 26, missing the estimate of -1.03 USD, resulting in a -32.46% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -0.48% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 10 analysts forecast an EPS of -1.24 USD, with revenue projected to reach -- USD, implying an decrease of -9.49% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Grace Therapeutics, Inc. Common Stock
Report Date
Jun 18, 2026 For Q4 26
Estimate
-$0.23
Actual
-$0.06
Surprise
+74.42%
FAQ
For Q1 2026, Viking Therapeutics, Inc reported EPS of -$1.37, missing estimates by -32.46%, and revenue of $0.00, 0% as expectations.
The stock price moved down -0.48%, changed from $31.33 before the earnings release to $31.18 the day after.
The next earning report is scheduled for Jul 29, 2026.
Based on 10 analysts, Viking Therapeutics, Inc is expected to report EPS of -$1.24 and revenue of -- for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement